Brief: Oncoarendi Therapeutics Signs Cooperation Deal Regarding R&D In Treatment Of Post-Covid-19 Complications

Molecure SA

10/09/2020 16:02

Sept 10 (Reuters) - Oncoarendi Therapeutics SA  OAT.WA :
    * SIGNS COOPERATION DEAL WITH BELGIAN RESEARCH INSTITUTE 
VLAAMS
INSTITUUT VOOR BIOTECHNOLOGIE
    * COOPERATION REGARDS RESEARCH AND DEVELOPMENT IN TREATMENT
OF
POST-COVID-19 COMPLICATIONS
    * COST OF RESEARCH AND DEVELOPMENT TO BE FINANCED BY THE
COMPANY
AND IS ESTIMATED AT ABOUT 0.8 MILLION ZLOTYS WITHIN TWO YEARS

Source text for Eikon:  ID:nEM5CNhNPa 
Further company coverage:  OAT.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))